These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6499837)
21. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)]. Berthoux FC; Freyria AM Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022 [TBL] [Abstract][Full Text] [Related]
22. Complement alterations in inflammatory bowel disease. Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435 [TBL] [Abstract][Full Text] [Related]
23. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus. Whaley K; Schur PH; Ruddy S Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347 [TBL] [Abstract][Full Text] [Related]
24. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III. Clardy CW; Forristal J; Strife CF; West CD Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424 [TBL] [Abstract][Full Text] [Related]
25. Serial determination of complement and specific antibody titres in Pseudomonas aeruginosa infection. Petrás G; Füst G; Adám MM Acta Microbiol Hung; 1984; 31(2):141-51. PubMed ID: 6464660 [TBL] [Abstract][Full Text] [Related]
26. The alternate complement pathway. A possible role in a patient with focal glomerular sclerosis. Stapleton FB; Linshaw MA; Cuppage FE; Kim YK; Quie PG Arch Pathol Lab Med; 1981 Mar; 105(3):160-3. PubMed ID: 6894082 [TBL] [Abstract][Full Text] [Related]
27. Role of complement in corneal inflammation. Mondino BJ; Brown SI; Rabin BS Trans Ophthalmol Soc U K (1962); 1978 Sep; 98(3):363-6. PubMed ID: 289218 [No Abstract] [Full Text] [Related]
28. Serum antibodies to Pseudomonas pseudoalcaligenes in metal workers exposed to infected metal-working fluids. Mattsby-Baltzer I; Edebo L; Järvholm B; Lavenius B Int Arch Allergy Appl Immunol; 1989; 88(3):304-11. PubMed ID: 2722255 [TBL] [Abstract][Full Text] [Related]
29. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement. Junker A; Baatrup G; Svehag SE; Wang P; Holmström E; Sturfelt G; Sjöholm AG Scand J Immunol; 1998 May; 47(5):481-6. PubMed ID: 9627133 [TBL] [Abstract][Full Text] [Related]
30. The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation? Harrison RA Semin Immunopathol; 2018 Jan; 40(1):15-35. PubMed ID: 29167939 [TBL] [Abstract][Full Text] [Related]
31. Schistosoma mansoni: complement activation in human and rodent sera by living parasites of various developmental stages. Ruppel A; Rother U; Vongerichten H; Diesfeld HJ Parasitology; 1983 Aug; 87 (Pt 1)():75-86. PubMed ID: 6604899 [TBL] [Abstract][Full Text] [Related]
32. Alternate and classical pathway components of complement in the normal cornea. Mondino BJ; Ratajczak HV; Goldberg DB; Schanzlin DJ; Brown SI Arch Ophthalmol; 1980 Feb; 98(2):346-9. PubMed ID: 6766301 [TBL] [Abstract][Full Text] [Related]
33. Complement activation by pneumococci associated with acute otitis media. Prellner K Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):213-6. PubMed ID: 39420 [TBL] [Abstract][Full Text] [Related]
34. Immunological and clinical responses to humidifier fever antigens. Belin L; Ekström NA; Falsen E Monogr Allergy; 1979; 14():146-9. PubMed ID: 574188 [No Abstract] [Full Text] [Related]
35. Microbial and immunological investigations and remedial action after an outbreak of humidifier fever. Edwards JH Br J Ind Med; 1980 Feb; 37(1):55-62. PubMed ID: 6768379 [TBL] [Abstract][Full Text] [Related]
36. [Hypersensitivity pneumonitis caused by a factory humidifier. A case report]. Sakurai M; Kinosita K; Kobayashi Y; Nishi Y; Nozawa M; Kawasaki M; Tabe K; Nagata M; Kuramitu K; Sakamoto Y; Shimizu Y Nihon Kokyuki Gakkai Zasshi; 2001 Mar; 39(3):190-4. PubMed ID: 11431913 [TBL] [Abstract][Full Text] [Related]
37. The role of properdin in the alternate pathway of complement activation. Götze O; Müller-Eberhard HJ J Exp Med; 1974 Jan; 139(1):44-57. PubMed ID: 4808709 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement. Farries TC; Lachmann PJ; Harrison RA Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783 [TBL] [Abstract][Full Text] [Related]
39. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3. Newman SL; Mikus LK J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200 [TBL] [Abstract][Full Text] [Related]
40. Study of Ps. pycoyanea strains isolated from pathological material. Kumari S; Bhatia SL; Agarwal DS Indian J Med Res; 1974 Apr; 62(4):484-90. PubMed ID: 4435859 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]